EQS-CMS: Fresenius Medical Care AG : Release of a capital market information

Fresenius Medical Care AG: Share buyback

 Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014

Share buyback – Interim Report

In the period from April 6, 2026, to April 10, 2026 (each inclusive), 4,500 shares were bought back within the framework of the second tranche of the share buyback of Fresenius Medical Care AG, the start of which was disclosed on January 12, 2026, pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No. 596/2014, Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052.

Shares were bought back as follows:

A total of 9,540,900 shares has been acquired within the framework of the second tranche of the share buyback.

The purchase of the shares is carried out by a credit institution commissioned by Fresenius Medical Care AG.

Fresenius Medical Care AG will provide regular information regarding the progress of the share buyback, including by posting its required disclosures at https://freseniusmedicalcare.com/en/investors/shares/share-buyback/.